Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Familial platelet disorder with predisposition to acute myelogenous leukaemia (FPD/AML, MIM 601399) is an autosomal dominant disorder characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukaemia (AML). Informative recombination events in 6 FPD/AML pedigrees with evidence of linkage to markers on chromosome 21q identified an 880-kb interval containing the disease gene. Mutational analysis of regional candidate genes showed nonsense mutations or intragenic deletion of one allele of the haematopoietic transcription factor CBFA2 (formerly AML1) that co-segregated with the disease in four FPD/AML pedigrees. We identified heterozygous CBFA2 missense mutations that co-segregated with the disease in the remaining two FPD/AML pedigrees at phylogenetically conserved amino acids R166 and R201, respectively. Analysis of bone marrow or peripheral blood cells from affected FPD/AML individuals showed a decrement in megakaryocyte colony formation, demonstrating that CBFA2 dosage affects megakaryopoiesis. Our findings support a model for FPD/AML in which haploinsufficiency of CBFA2 causes an autosomal dominant congenital platelet defect and predisposes to the acquisition of additional mutations that cause leukaemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [48]
In the citing paper
“Germ line mutations in RUNX-1 cause familial platelet disorder with the propensity to develop acute myelogenous leukemia (FPD/AML), a rare autosomal dominant disorder characterized by quantitative and qualitative platelet defects and a high incidence of developing myelodysplastic syndrome (MDS) and leukemia”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [48]
Citations
Cites
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355 · cited 1×
“Fusion of PDGF Receptor β to a novel ETS-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.”
BackgroundWang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Self-citationGolub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Self-citationOncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.
Weinberg, R. A. (1989) · PubMed · Cited by 949
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732 · cited 1×
“; the CBFB / MYH11 fusion associated with inv(16) myelomonocytic leukaemia with eosinophili”
BackgroundFusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
Self-citationShivdasani, R. A., Rosenblatt, M. F., Zucker-Franklin, D., Jackson, C. W., Hunt, P., Saris, C. J. M., & Orkin, S. H. (1995) · Cell · doi:10.1016/0092-8674(95)90531-6 · Cited by 693 · cited 1×
“It is notable that mice hemizygous for genes required for megakaryopoiesis, such as Gata1 , Nfe2 and fog , have apparent platelet defect”
BackgroundShivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674 · cited 1×
“It is notable that mice hemizygous for genes required for megakaryopoiesis, such as Gata1 , Nfe2 and fog , have apparent platelet defect”
Background
Cited by
Items 801–900 of 1,000
Zerella, J. R., Homan, C. C., Arts, P., Brown, A. L., Scott, H. S., & Hahn, C. N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1183318 · Cited by 6
A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22)
Abe, A., Katsumi, A., Kobayashi, M., Okamoto, A., Tokuda, M., Kanie, T., Yamamoto, Y., Naoe, T., & Emi, N. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.10.001 · Cited by 8
Studying leukemia stem cell properties and vulnerabilities with human iPSCs
Spyrou, N., & Papapetrou, E. P. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102117 · Cited by 6
“It is often translocated in sporadic AML and is the target of somatic and germline loss-of-function or dominant negative mutations, causing familial predisposition to AML (RUNX1-familial platelet disorder, FPD) (Song et al., 1999; Hatlen et al., 2012; Sood et al., 2017).”
New dead/H-box helicase gene (ddx41) mutation in an Italian family with recurrent leukemia
Fazio, F., Quintini, M., Carmosino, I., Matteucci, C., Miulli, E., Pellanera, F., Lucani, B., Ansuinelli, M., Breccia, M., Mecucci, C., et al. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1910689 · Cited by 6
O'Connor, T. E., Shaw, R. C., Madero‐Marroquin, R., & Roloff, G. W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1180439 · Cited by 6
“Strikingly, clonal hematopoiesis has been observed in a majority of asymptomatic RUNX1 germline variant carriers, even before age 50.”
BackgroundInfluentialAcute myeloid leukemia in a child with hereditary thrombocytopenia
Rheingold, S. R. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20677 · Cited by 6
“Mutations or deletions ofAML1(CBFA2) gene are found in these patients and are implicated in the pathogenesis of AML [1,15].”
BackgroundCazzaniga, G., Nigro, L. L., Cifola, I., Milone, G., Schnittger, S., Haferlach, T., Mirabile, E., Costantino, F., Martelli, M. P., Mastrodicasa, E., et al. (2008) · Leukemia · doi:10.1038/leu.2008.170 · Cited by 6
Monitoring and treatment of MDS in genetically susceptible persons
Davies, S. M. (2019) · Hematology · doi:10.1182/hematology.2019000020 · Cited by 6
“Germline mutations in RUNX1 Heterozygous germline RUNX1 mutations were first described in 6 families, each carrying a different mutation and transmitted in an autosomal dominant manner in 1999.(42) Expressivity is variable, and individuals carrying germline RUNX1 may be asymptomatic throughout their lifetime or develo…”
BackgroundYoshino, H., Nishiyama, Y., Kamma, H., Chiba, T., Fujiwara, M., Karaho, T., Kogashiwa, Y., Morio, T., Yan, K., Bessho, F., et al. (2020) · International Journal of Hematology · doi:10.1007/s12185-020-02885-y · Cited by 6
Thrombocytopenia in the Newborn
Roberts, I. A. G., & Chakravorty, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00045-6 · Cited by 6
Family with acute myelocytic leukemia, breast, ovarian, and gastrointestinal cancer
Lynch, H. T., Weisenburger, D. D., Quinn‐Laquer, B., Snyder, C., Lynch, J. F., Lipkin, S. M., & Sanger, W. G. (2002) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00537-x · Cited by 6
The Influence of Premeiotic Clusters of Mutation on Indirect Estimations of Mutation Rate
Gong, Y., Gu, S., & Woodruff, R. C. (2005) · Human Heredity · doi:10.1159/000089955 · Cited by 6
Escher, R., Hagos, F., Michaud, J., Sveen, L., Horwitz, M. S., Olopade, O. I., & Scott, H. S. (2004) · Leukemia · doi:10.1038/sj.leu.2403308 · Cited by 6
Jakubowiak, A. J., Cammenga, J., Sokolic, R. A., Álvarez, S., Jackson, G., Hedvat, C. V., & Nimer, S. D. (2000) · Current Oncology Reports · doi:10.1007/s11912-000-0083-z · Cited by 8
Frequency and Functional Characterization of RUNX1 Germline Variants in Myeloid Neoplasms
Nitschke, N. J., Almosailleakh, M., Niu, Y., Hansen, J. W., Raaschou‐Jensen, K., Jespersen, J. S., Severinsen, M. T., Roug, A. S., Frödin, M., Weischenfeldt, J., et al. (2023) · Human Mutation · doi:10.1155/2023/4738660 · Cited by 5
“MDS was the most frequent diagnosis in our cohort, followed by AML and CCUS; see Supplemental Figure 1.”
InfluentialHereditary Hematopoietic Malignancies: Considerations for Optimizing Diagnosis and Management
Trottier, A. M., Cunningham, L., & Godley, L. A. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01699-7 · Cited by 5
Obata, M., Tsutsumi, S., Makino, S., Takahashi, K., Watanabe, N., Yoshida, T., Tamiya, G., & Kurachi, H. (2014) · Platelets · doi:10.3109/09537104.2014.912750 · Cited by 7
“601399) [11, 22, 23], the RUNX1 mutation was predicted to be causative mutation of the thrombocytopenia and platelet disorder in this case.”
BackgroundInfluentialC11orf21, a novel RUNX1 target gene, is down-regulated by RUNX1-ETO
Matsumoto, A., Yoshida, T., Shima, T., Yamasaki, K., Tadagaki, K., Kondo, N., Kuwahara, Y., Zhang, D., & Okuda, T. (2022) · BBA Advances · doi:10.1016/j.bbadva.2022.100047 · Cited by 5
Lim, J., Ross, D. M., Brown, A. L., Scott, H. S., & Hahn, C. N. (2024) · Leukemia Research · doi:10.1016/j.leukres.2024.107566 · Cited by 5
The False Paradigm of RUNX3 Function as Tumor Suppressor in Gastric Cancer
Lotem, J., Levanon, D., Negreanu, V., & Groner, Y. (2013) · Journal of Cancer Therapy · doi:10.4236/jct.2013.41a003 · Cited by 7
“The association of RUNX1 to cancer development in humans is multifaceted, including predisposition to development of AML in families with germline RUNX1 point mutations or deletions [65,66], frequent point mu-”
Subsequent Malignant Neoplasms After Hematopoietic Cell Transplantation
Bhatia, R., & Bhatia, R. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch104 · Cited by 5
Mutation-Driven Therapy in MDS
Swoboda, D. M., & Sallman, D. A. (2019) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-019-00554-4 · Cited by 5
Genetic predisposition in pediatric oncology
Pruteanu, D. P., Olteanu, D. E., Cosnarovici, R., Mihut, E., & Nagy, V. M. (2020) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1576 · Cited by 7
“It is caused by monoallelic mutation of RUNX 1 gene on the 21q22 chromosome band [70].”
BackgroundTo T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition
Avagyan, S., & Brown, A. L. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152464 · Cited by 5
Kamiya, L. J., Barozzi, S., Isidori, F., Ganiewich, D., Luca, G. D., Bozzi, V., Marta, R. F., Melazzini, F., Pippucci, T., Heller, P. G., et al. (2024) · British Journal of Haematology · doi:10.1111/bjh.19776 · Cited by 5
Leukemias, Lymphomas, and Other Related Disorders
Zhang, Y., & Rowley, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00079-3 · Cited by 7
Callea, M., Fattori, F., Bertini, E., Cammarata‐Scalisi, F., Callea, F., & Bellacchio, E. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1274980 · Cited by 5
“tion of RUNX1 found in cases of familial platelet disorder with predisposition to AML [9], and characterized by”
BackgroundXia, L., Cao, Y.-J., Guo, Y., Ba, G., Luo, Q., Shi, H., Feng, Y., & Yin, S. (2019) · Disease Markers · doi:10.1155/2019/8705989 · Cited by 5
“The special phenotype of COL4A3 in this study may also be due to haploinsufficiency [34].”
BackgroundWhen should transplant physicians think about familial blood cancers?
Trottier, A. M., Bannon, S. A., Bashir, Q., Carraway, H. E., Hofmann, I., & Godley, L. A. (2019) · Advances in Cell and Gene Therapy · doi:10.1002/acg2.68 · Cited by 5
Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies
Sakurai, M., Nannya, Y., Yamazaki, R., Yamaguchi, K., Koda, Y., Abe, R., Yokoyama, K., Ogawa, S., & Mori, T. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04430-1 · Cited by 5
Kansal, R. (2021) · Journal of Hematology Research · doi:10.12974/2312-5411.2021.08.3 · Cited by 5
GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE
Fabozzi, F., & Mastronuzzi, A. (2023) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2023.032 · Cited by 5
“myeloid malignancy (FDP-MM), initially described in 1999.(30) Several mutations have been identified to date, including larger gene deletions, nonsense or frameshift”
BackgroundShortened Telomeres: A Driving Force Behind Leukemia?
Pepper, C. J., & Baird, D. M. (2010) · Future Oncology · doi:10.2217/fon.10.135 · Cited by 6
“Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J: Mutation of CEBPA in familial acute myeloid leukemia.”
BackgroundPlace de la cytogénétique dans la prise en charge des syndromes myélodysplasiques primaires
Raynaud, S. (2003) · Pathologie Biologie · doi:10.1016/s0369-8114(03)00111-1 · Cited by 5
Mitotic recombination in haematological malignancy
Raghavan, M., Gupta, M., Molloy, G. Y., Chaplin, T., & Young, B. D. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.030 · Cited by 5
“In familial platelet disorder, it causes haploinsufficiency, as there is only a single allele affected (Song et al., 1999), but in de novo AML, especially FAB type M0, there are frequent biallelic mutations (Roumier et al., 2003, Roumier et al., 2006, Silva et al., 2003).”
BackgroundCarter, T. L., Terry, P. A., Gottardo, N. G., Baker, D. L., Kees, U. R., & Watt, P. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(04)00861-7 · Cited by 5
Disorders of Red Cells and Platelets
MBBS, F. B. J. B. (2006) · Wiley eBooks · doi:10.1002/9780470987551.ch8 · Cited by 5
Wiernik, P. H. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-014-0323-3 · Cited by 5
Benson, K. F., & Horwitz, M. S. (2006) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.11.002 · Cited by 5
Catani, M. V., Gasperi, V., Savini, I., & Principe, D. D. (2015) · Wiley eBooks · doi:10.1002/9780470015902.a0002253 · Cited by 5
Insights into germline predisposition to pediatric lymphoid malignancies
Thapa, R., Nichols, K. E., & Sharma, R. (2025) · Leukemia · doi:10.1038/s41375-025-02750-z · Cited by 4
The splicing factor PTBP1 interacts with RUNX1 and is required for leukemia cell survival
Dhir, A., Ethell, A., Watkins, R., Lam, C. K., Tur-Rodriguez, K., Persinger, J., Dobish, K. K., Panda, S., Buckley, S. M., Swenson, S. A., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02799-w · Cited by 7
Cytogenetic Diagnosis of Myelodysplastic Syndromes
Olney, H. J., & Beau, M. M. L. (2006) · Springer eBooks · doi:10.1007/3-540-30794-x_6 · Cited by 6
Ullah, H., Zhang, B., Sharma, N. K., McCrea, P. D., & Srivastava, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.981020 · Cited by 4
“In particular, the mutations R201Q (Uniprot: R174Q) and R166Q (Uniprot: R139Q) are predicted to disrupt DNA binding, and NMR-derived structures show that both have arginine substitutions at residue positions known to be important for DNA association (Berardi et al., 1999; Song et al., 1999).”
BackgroundCarpio‐Cano, F. D., Mao, G., Goldfinger, L. E., Wurtzel, J. G. T., Guan, L., Alam, M. A., Lee, K., Poncz, M., & Rao, A. K. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011098 · Cited by 5
Self-citationThe Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers
Monovich, A. C., Gurumurthy, A., & Ryan, R. J. H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_13 · Cited by 4
The genetics of acute myeloid leukemias
Trottier, A. M., & Owen, C. (2019) · Wiley eBooks · doi:10.1002/9781119252863.ch3 · Cited by 5
Mouse models of diseases of megakaryocyte and platelet homeostasis
Carmichael, C., & Alexander, W. S. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9336-4 · Cited by 4
“Linkage analysis identified lossof-function mutations in the runt-related transcription factor RUNX1 (also known as CBFA2 and AML1) as the cause of this disorder (Song et al. 1999).”
BackgroundCongenital and Acquired Disorders of Platelet Function and Number
Jobe, S. M., & Paola, J. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00009-1 · Cited by 5
Cantor, A. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00028-7 · Cited by 4
Barabino, S. M. L., Citterio, E., & Ronchi, A. E. (2021) · Cancers · doi:10.3390/cancers13153753 · Cited by 4
“Mutations causing RUNX1 deficiency are detrimental for myeloid differentiation: heterozygous germline mutations result in a highly penetrant familial platelet disorder with a predisposition to AML [105] and somatic heterozygous RUNX1 mutations are recurrent in myelodysplastic syndromes and in AML with adverse outcome…”
BackgroundRare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults
Brown, A. M., & Batra, S. (2024) · Cancers · doi:10.3390/cancers16050997 · Cited by 5
McMilin, K. D. (2002) · Transfusion · doi:10.1046/j.1525-1438.2002.00086.x · Cited by 4
Tijssen, M. R., Moreau, T., & Ghevaert, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_2 · Cited by 5
“2 Familial Platelet Disorder/AML The complex role of RUNX1 in MK differentiation is illustrated by the autosomal dominant human syndrome familial platelet disorder with propensity to develop acute myeloid leukaemia (FDP/AML) in which germline heterozygous RUNX1 mutations lead not only to thrombocytopenia but also to i…”
BackgroundTakaoka, K., Koya, J., Yoshimi, A., Toya, T., Kobayashi, T., Nannya, Y., Nakazaki, K., Arai, S., Ueno, H., Usuki, K., et al. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1734595 · Cited by 4
“Indeed, Runt-related transcription factor 1 (RUNX1) mutations were reported in pedigrees with familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML) [24,25].”
BackgroundLambert, M. P., & Poncz, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00047-x · Cited by 4
Self-citationBoultwood, J., & Wainscoat, J. S. (2005) · Wiley eBooks · doi:10.1002/9780470987063.ch8 · Cited by 4
Papadantonakis, N., & Ravid, K. (2009) · Springer eBooks · doi:10.1007/978-0-387-85816-6_5 · Cited by 6
Evidence of early start for common acute lymphoblastic leukaemia
Felix, C. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00339-6 · Cited by 5
Self-citationEscher, R., Jones, A., Hagos, F., Carmichael, C., Horwitz, M. S., Olopade, O. I., & Scott, H. S. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20084 · Cited by 5
“A germ-line deletion of RUNX1 resulting in haploinsufficiency was described in one familial leukemia pedigree (Song et al., 1999).”
BackgroundCrystallization and preliminary studies of the DNA-binding runt domain of AML1
Bäckström, S., Huang, S., Wolf‐Watz, M., Xie, X., Härd, T., Grundström, T., & Sauer, U. H. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900015791 · Cited by 4
“Point mutations or deletions in the Runx1 gene are also found in several percent of acute leukaemias and in the familial platelet disorder FPD/AML and cluster within the runt domain (Lee et al., 1997; Osato et al., 1999; Song et al., 1999; Westendorf & Hiebert, 1999).”
BackgroundAcute megakaryoblastic leukemia and loss of the RUNX1 gene
Berger, R., Busson, M., Dastugue, N., Radford‐Weiss, I., Michaux, L., Hagemeijer, A., Quilichini, B., Benattar, L. K., Bernard, O., & Romana, S. P. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.05.002 · Cited by 4
Rabbolini, D. J., Wård, C., & Stevenson, W. S. (2016) · EMJ Hematology · doi:10.33590/emjhematol/10314585 · Cited by 3
Fluctuating asymmetry and blood parameters in three endangered gazelle species
Cuervo, J. J., Dhaoui, M., & Espeso, G. (2011) · Mammalian Biology · doi:10.1016/j.mambio.2011.01.007 · Cited by 3
RUNX/CBF Transcription Factors☆
Lam, K., & Zhang, D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98749-x · Cited by 3
Congenital and Acquired Disorders of Platelet Function and Number
Jobe, S. M., & Paola, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00010-5 · Cited by 3
Germline RUNX1 variants in paediatric patients in a French specialised centre
Liu, C., Ballerini, P. F., Nguyen, G., Mincheva, Z., Copin, B., Bouslama, B., Leverger, G., Petit, A., Favier, R., Lapillonne, H., et al. (2022) · eJHaem · doi:10.1002/jha2.594 · Cited by 3
“Variants were named according to the Human Genome Variation Society (cDNAnumbering uses+1 as the A of the ATG translation initiation codon, and protein numbering takes the initiation codon as codon 1), based on RUNX1c.”
BackgroundInfluentialGermline Predisposition in Hematologic Malignancies
Kansal, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00126-8 · Cited by 3
Qiu, H., Zhang, C., Ma, X., & Li, Y. (2025) · Oncology Reports · doi:10.3892/or.2025.8887 · Cited by 3
Molecular genetics of acute myeloid leukemia
Gruber, T. A., & Downing, J. R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.009 · Cited by 3
Chen, W. L., Luo, D.-F., Gao, C., Ding, Y., & Wang, S. Y. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20154430 · Cited by 3
Molecular genetics of acute myeloid leukemia
Lorsbach, R. B., & Downing, J. R. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.012 · Cited by 4
Heritable predispositions to childhood hematologic malignancies
Le, D., Shannon, K., & Lange, B. J. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.014 · Cited by 4
Familial myelodysplastic syndromes.
Mr, A., Pereira, P. M. L. P., & Ramapuram, J. (2000) · PubMed · Cited by 3
Molecular genetics of acute lymphoblastic leukemia
Mullighan, C. G. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.008 · Cited by 4
Secondary Malignancies After Hematopoietic Cell Transplantation
Bhatia, S., & Bhatia, R. (2003) · Wiley eBooks · doi:10.1002/9780470987070.ch70 · Cited by 3
Loci other than 21q22.12 (RUNX1) and 16q21–23.2 cause familial AML
Sellick, G. S., Pritchard‐Jones, K., Shepherd, V., Swansbury, J. G., Catovsky, D., & Houlston, R. S. (2005) · Leukemia · doi:10.1038/sj.leu.2403648 · Cited by 3
López, A., Baida, A., Marcos, R., Xamena, N., & Velázquez, A. (2002) · DNA repair · doi:10.1016/s1568-7864(02)00146-5 · Cited by 4
“Existen algunos ejemplos de haploinsuficiencia en humanos y ratón (Venkatachalam et al., 1998; Song et al., 1999) en los que los individuos portadores de una mutación en heterocigosis, que inactiva un solo alelo de un gen supresor de tumores, presentan una mayor incidencia de tumores,…”
BackgroundBernard, O., & Berger, R. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90020-9 · Cited by 3
Ebert, B. L. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.02.014 · Cited by 3
Genetic panels in young patients with bone marrow failure: are they clinically relevant?
Dezern, A. E., & Brodsky, R. A. (2016) · Haematologica · doi:10.3324/haematol.2016.152389 · Cited by 3
“These have been reported to cause Fanconi anemia,10 congenital amegakaryocytic thrombocytopenia,8 dyskeratosis congenita,7 and Shwachman-Diamond syndrome.11 Additionally mutations in GATA2 and RUNX1 are known to have an inherited predisposition to leukemia and MDS.12,13 The fifteenth patient with mutated bone marrow D…”
BackgroundInfluentialProgress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective
Basquiera, A. L., Andreoli, V., Grille, S., & Belli, C. (2025) · Genes · doi:10.3390/genes16060687 · Cited by 2
Genetic influences on haematopoiesis
Poeschla, M., & Sankaran, V. G. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00947-1 · Cited by 3
“Mutations in RUNX1 , first identified in the 1990s as the cause of familial platelet disorder with predisposition to myeloid leukaemia, have revealed essential functions in megakaryopoiesis and leukaemogenesis 73,74 .”
Chi, K., Li, Y., Xu, L., & Wang, X. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1292357 · Cited by 2
Wu, F., Song, T., Yao, Y., & Song, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216203 · Cited by 2
UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8
Fukuyama, T., Kitamura, T., & Kozu, T. (2022) · International Journal of Hematology · doi:10.1007/s12185-022-03303-1 · Cited by 2
“Third, point mutations are observed in leukemia, myelodysplastic syndromes (MDS), and familial platelet disorder with a predisposition to acute myeloid leukemia [31, 32].”
BackgroundMolecular pathophysiology of germline mutations in acute myeloid leukemia
Nagata, Y. (2024) · International Journal of Hematology · doi:10.1007/s12185-024-03824-x · Cited by 3
“Germline mutations in RUNX1 , first described in 1999 by Song et al. [31], result in the loss of RUNX1 protein function through point mutations that produce proteins acting as dominant negatives as well as nonsense or frameshift mutations and larger deletions [32].”
Carpio‐Cano, F. D., Songdej, N., Guan, L., Mao, G., Goldfinger, L. E., Wurtzel, J. G. T., Lee, K., Lambert, M. P., Poncz, M., & Rao, A. K. (2025) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2025.102680 · Cited by 2
Self-citationKajdic, A., Deuitch, N. T., Bresciani, E., Davis, J., Craft, K., Chong, S., Liu‐Chittenden, Y., Young, D. J., Kanakry, C. G., Cunningham, L., et al. (2025) · British Journal of Haematology · doi:10.1111/bjh.19989 · Cited by 2
Retroviral integration sites (RIS) mark cis-regulatory elements
Ng, C. E. L., Ito, Y., & Osato, M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.10.008 · Cited by 2
“RUNX1 haploinsufficiency causes familial platelet disorder with a predisposition to acute myeloid leukemia (FPD/AML) [68,69].”
BackgroundNovak, K. D. (1999) · Nature Medicine · doi:10.1038/70923 · Cited by 2
Myelodysplastic Syndrome in Children
Niemeyer, C. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-36229-3_14 · Cited by 2
Hasle, H. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.022 · Cited by 2
Genetic Basis of Inherited Bone Marrow Failure Syndromes
Dror, Y. (2011) · InTech eBooks · doi:10.5772/17388 · Cited by 3
Cryptic chromosomal aberrations waiting to be discovered
Lahortiga, I., & Cools, J. (2005) · Leukemia · doi:10.1038/sj.leu.2404078 · Cited by 2
Absence of Mutations on the SNF5 Gene in Hematological Neoplasms with Chromosome 22 Abnormalities
Mori, N., Inoue, K., Okada, M., & Motoji, T. (2011) · Acta Haematologica · doi:10.1159/000324932 · Cited by 2
“Alternatively, haploinsufficiency of the SNF5 gene may contribute to the development of these neoplasms. This has been shown in familial thrombocytopenia disorder with the loss of one AML1 allele associated with an increased proclivity to develop AML [”
BackgroundRunx1/AML1 is a Guardian of Hematopoietic Stem Cells
Motoda, L., Osato, M., & Ito, Y. (2008) · Current Cancer Therapy Reviews · doi:10.2174/157339408785294302 · Cited by 2
“Biallelic mutations of RUNX1 are frequently found in the acute myeloid leukemia (AML) M0 subtype and monoallelic mutations cause familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML), sporadic leukemia, and myelodysplastic syndrome (MDS) [22-26].”
BackgroundLee, K., Shim, J., Lee, J., & Lee, J. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.007898 · Cited by 2
“Familial platelet disorder, which is caused by haploinsufficiency of RUNX1, leads to acute myelogenous leukemia (Song et al. 1999).”
BackgroundStaib, P., Lippl, S., & Spiekermann, K. (2015) · best practice onkologie · doi:10.1007/s11654-015-0247-9 · Cited by 4
Cancer cell(s) cycle sequencing reveals universal mechanisms of apoptosis.
Marretta, R. M. A., & Ales, F. (2010) · PubMed · doi:10.3970/mcb.2010.007.225 · Cited by 2
Metadata
- Authors
- Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., Loh, M., Felix, C., Roy, D.-C., Busque, L., Kurnit, D., Willman, C., Gewirtz, A. M., Speck, N. A., Bushweller, J. H., Li, F. P., Gardiner, K., Poncz, M., Maris, J. M., & Gilliland, D. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Brown University (US)
- University of Pennsylvania (US)
- Leicester Royal Infirmary (GB)
- St Vincent Hospital (US)
- Hôpital Maisonneuve-Rosemont (CA)
- University of Michigan (US)
- University of New Mexico (US)
- Dartmouth College (US)
- University of Virginia (US)
- Harvard University (US)
- Roosevelt Institute (US)
- Corresponding author
- Gilliland, D. Gary
- ORCID
- Venue
- Nature Genetics
- Published
- 1999-10
- Volume
- 23
- Issue
- 2
- Pages
- 166-175
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1739103212
- Cited by
- 1,100
- References
- 49
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 27 · 2023: 32 · 2022: 29 · 2021: 36 · 2020: 46 · 2019: 33 · 2018: 26 · 2017: 61 · 2016: 54 · 2015: 35 · 2014: 30 · 2013: 33 · 2012: 53
- FWCI
- 25.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r29ai039536-04)
- National Cancer Institute (R01CA081932, R01-CA78545, R01 CA81932, R01CA078545)
- National Institute of Allergy and Infectious Diseases (R29 AI39536)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- RUNX1, haploinsufficiency, autosomal dominant inheritance, missense mutations, megakaryopoiesis, megakaryocyte colony formation, platelet disorders, chromosome 21q, nonsense mutation, intragenic deletion
- MeSH terms
- Amino Acid Sequence, Base Sequence, Blood Platelets, Chromosome Mapping, Colony-Forming Units Assay, DNA Mutational Analysis, DNA-Binding Proteins, Family Health, Female, Genotype, Hematopoiesis, Heterozygote, Humans, Male, Megakaryocytes, Molecular Sequence Data, Mutation, Pedigree, Proto-Oncogene Proteins, RNA, Sequence Homology, Nucleic Acid, Thrombocytopenia, Transcription Factors, Leukemia, Myeloid, Acute, Sequence Deletion, Sequence Homology, Amino Acid, In Situ Hybridization, Fluorescence, Microsatellite Repeats, Genetic Predisposition to Disease, Reverse Transcriptase Polymerase Chain Reaction, Core Binding Factor Alpha 2 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.